IBB holdingswhat does iShares Biotechnology ETF hold?
Mayores posiciones según el reporte SEC Formulario N-PORT más reciente del fondo (reportado trimestralmente, presentado con rezago). Los porcentajes son sobre los activos netos. SEC Formulario N-PORT · al 2025-09-30
Las 150 mayores posicionesPeso de las 10 mayores posiciones: 59.0%al 2025-09-30
| # | Posición | Peso | Valor |
|---|---|---|---|
| 1 | BlackRock Funds IIIBISXX | 13.18% | $783.12M |
| 2 | Vertex Pharmaceuticals, Inc.VRTX | 7.66% | $455.33M |
| 3 | Gilead Sciences, Inc.GILD | 7.52% | $446.54M |
| 4 | Amgen, Inc.AMGN | 7.50% | $445.79M |
| 5 | Regeneron Pharmaceuticals, Inc.REGN | 5.70% | $338.58M |
| 6 | Alnylam Pharmaceuticals, Inc.ALNY | 5.68% | $337.49M |
| 7 | IQVIA Holdings, Inc.IQV | 3.18% | $188.73M |
| 8 | Argenx SEARGX | 3.15% | $187.13M |
| 9 | Insmed, Inc.INSM | 2.95% | $175.52M |
| 10 | Mettler-Toledo International, Inc.MTD | 2.49% | $148.05M |
| 11 | Natera, Inc.NTRA | 2.11% | $125.58M |
| 12 | BeOne Medicines Ltd.ONC | 2.11% | $125.18M |
| 13 | Biogen, Inc.BIIB | 2.03% | $120.87M |
| 14 | United Therapeutics Corp.UTHR | 1.82% | $108.13M |
| 15 | Waters Corp.WAT | 1.77% | $105.00M |
| 16 | Incyte Corp.INCY | 1.62% | $96.48M |
| 17 | Illumina, Inc.ILMN | 1.41% | $83.67M |
| 18 | Genmab A/SGMAB | 1.38% | $81.91M |
| 19 | Neurocrine Biosciences, Inc.NBIX | 1.34% | $79.87M |
| 20 | Medpace Holdings, Inc.MEDP | 1.16% | $68.78M |
| 21 | Exelixis, Inc.EXEL | 1.07% | $63.47M |
| 22 | Ionis Pharmaceuticals, Inc.IONS | 1.03% | $60.98M |
| 23 | BioMarin Pharmaceutical, Inc.BMRN | 1.02% | $60.40M |
| 24 | Madrigal Pharmaceuticals, Inc.MDGL | 0.92% | $54.53M |
| 25 | Moderna, Inc.MRNA | 0.88% | $52.32M |
| 26 | Bio-Techne Corp.TECH | 0.85% | $50.43M |
| 27 | Ascendis Pharma A/S | 0.84% | $50.10M |
| 28 | Halozyme Therapeutics, Inc.HALO | 0.84% | $50.02M |
| 29 | Bridgebio Pharma, Inc.BBIO | 0.84% | $49.66M |
| 30 | Tempus AI, Inc.TEM | 0.77% | $45.78M |
| 31 | Charles River Laboratories International, Inc.CRL | 0.76% | $44.89M |
| 32 | Revolution Medicines, Inc.RVMD | 0.75% | $44.61M |
| 33 | Repligen Corp.RGEN | 0.71% | $41.91M |
| 34 | Roivant Sciences Ltd. | 0.65% | $38.36M |
| 35 | Cytokinetics, Inc.CYTK | 0.64% | $37.92M |
| 36 | Merus NV | 0.64% | $37.86M |
| 37 | BioNTech SEBNTX | 0.62% | $36.68M |
| 38 | Rhythm Pharmaceuticals, Inc.RYTM | 0.62% | $36.63M |
| 39 | Verona Pharma plc | 0.59% | $34.87M |
| 40 | CRISPR Therapeutics AG | 0.55% | $32.90M |
| 41 | Avidity Biosciences, Inc. | 0.50% | $29.79M |
| 42 | Axsome Therapeutics, Inc.AXSM | 0.50% | $29.47M |
| 43 | Alkermes plc | 0.48% | $28.43M |
| 44 | PTC Therapeutics, Inc.PTCT | 0.46% | $27.51M |
| 45 | Vaxcyte, Inc.PCVX | 0.45% | $26.64M |
| 46 | Arrowhead Pharmaceuticals, Inc.ARWR | 0.44% | $26.10M |
| 47 | Krystal Biotech, Inc.KRYS | 0.44% | $25.88M |
| 48 | Legend Biotech Corp.LEGN | 0.41% | $24.54M |
| 49 | Protagonist Therapeutics, Inc.PTGX | 0.39% | $23.02M |
| 50 | Nuvalent, Inc. | 0.38% | $22.77M |
| 51 | Crinetics Pharmaceuticals, Inc.CRNX | 0.36% | $21.39M |
| 52 | ACADIA Pharmaceuticals, Inc.ACAD | 0.35% | $21.06M |
| 53 | Arcellx, Inc. | 0.34% | $20.02M |
| 54 | ADMA Biologics, Inc.ADMA | 0.34% | $19.92M |
| 55 | Akero Therapeutics, Inc. | 0.33% | $19.78M |
| 56 | Bruker Corp.BRKR | 0.33% | $19.72M |
| 57 | Kymera Therapeutics, Inc.KYMR | 0.33% | $19.65M |
| 58 | Mirum Pharmaceuticals, Inc.MIRM | 0.30% | $17.57M |
| 59 | Xenon Pharmaceuticals, Inc.XENE | 0.29% | $17.52M |
| 60 | uniQure NV | 0.28% | $16.74M |
| 61 | Scholar Rock Holding Corp. | 0.27% | $16.27M |
| 62 | Ultragenyx Pharmaceutical, Inc. | 0.27% | $15.90M |
| 63 | Veracyte, Inc. | 0.26% | $15.56M |
| 64 | Zai Lab Ltd. | 0.26% | $15.44M |
| 65 | Amicus Therapeutics, Inc. | 0.24% | $13.97M |
| 66 | Apellis Pharmaceuticals, Inc. | 0.23% | $13.91M |
| 67 | Summit Therapeutics, Inc. | 0.23% | $13.66M |
| 68 | Tarsus Pharmaceuticals, Inc. | 0.23% | $13.51M |
| 69 | Beam Therapeutics, Inc. | 0.22% | $13.06M |
| 70 | Ideaya Biosciences, Inc. | 0.22% | $12.94M |
| 71 | Agios Pharmaceuticals, Inc. | 0.22% | $12.87M |
| 72 | Adaptive Biotechnologies Corp. | 0.22% | $12.81M |
| 73 | 89bio, Inc. | 0.21% | $12.64M |
| 74 | Newamsterdam Pharma Co. NV | 0.21% | $12.27M |
| 75 | Travere Therapeutics, Inc. | 0.21% | $12.23M |
| 76 | Arcutis Biotherapeutics, Inc. | 0.20% | $11.62M |
| 77 | CG oncology, Inc. | 0.19% | $11.14M |
| 78 | BlackRock Funds III | 0.19% | $11.13M |
| 79 | Denali Therapeutics, Inc. | 0.18% | $10.83M |
| 80 | Sarepta Therapeutics, Inc. | 0.18% | $10.56M |
| 81 | GRAIL, Inc. | 0.18% | $10.42M |
| 82 | Intellia Therapeutics, Inc. | 0.17% | $10.29M |
| 83 | Recursion Pharmaceuticals, Inc. | 0.16% | $9.58M |
| 84 | Twist Bioscience Corp. | 0.16% | $9.56M |
| 85 | Cogent Biosciences, Inc. | 0.16% | $9.53M |
| 86 | Mineralys Therapeutics, Inc. | 0.16% | $9.53M |
| 87 | MannKind Corp. | 0.16% | $9.43M |
| 88 | Vericel Corp. | 0.16% | $9.26M |
| 89 | BioCryst Pharmaceuticals, Inc. | 0.15% | $9.07M |
| 90 | Disc Medicine, Inc. | 0.15% | $8.95M |
| 91 | Apogee Therapeutics, Inc. | 0.15% | $8.62M |
| 92 | Centessa Pharmaceuticals plc | 0.14% | $8.60M |
| 93 | Vera Therapeutics, Inc. | 0.14% | $8.32M |
| 94 | Dyne Therapeutics, Inc. | 0.14% | $8.18M |
| 95 | Biohaven Ltd. | 0.14% | $8.18M |
| 96 | Janux Therapeutics, Inc. | 0.13% | $7.80M |
| 97 | Aurinia Pharmaceuticals, Inc. | 0.13% | $7.74M |
| 98 | 10X Genomics, Inc. | 0.13% | $7.61M |
| 99 | Novavax, Inc. | 0.13% | $7.56M |
| 100 | Immunocore Holdings plc | 0.13% | $7.56M |
| 101 | Syndax Pharmaceuticals, Inc. | 0.13% | $7.56M |
| 102 | Novocure Ltd. | 0.13% | $7.54M |
| 103 | Stevanato Group SpA | 0.13% | $7.53M |
| 104 | Zymeworks, Inc. | 0.12% | $7.35M |
| 105 | Edgewise Therapeutics, Inc. | 0.12% | $7.13M |
| 106 | Grifols SA | 0.12% | $7.13M |
| 107 | Galapagos NV | 0.12% | $7.09M |
| 108 | Dynavax Technologies Corp. | 0.11% | $6.83M |
| 109 | Immunovant, Inc. | 0.11% | $6.71M |
| 110 | AbCellera Biologics, Inc. | 0.11% | $6.69M |
| 111 | LENZ Therapeutics, Inc. | 0.11% | $6.60M |
| 112 | Structure Therapeutics, Inc. | 0.11% | $6.59M |
| 113 | Stoke Therapeutics, Inc. | 0.11% | $6.36M |
| 114 | Mesoblast Ltd. | 0.10% | $6.20M |
| 115 | Praxis Precision Medicines, Inc. | 0.10% | $6.18M |
| 116 | WaVe Life Sciences Ltd. | 0.09% | $5.48M |
| 117 | Amylyx Pharmaceuticals, Inc. | 0.09% | $5.33M |
| 118 | Alvotech SA | 0.09% | $5.26M |
| 119 | Arcus Biosciences, Inc. | 0.09% | $5.25M |
| 120 | Spyre Therapeutics, Inc. | 0.09% | $5.05M |
| 121 | Nuvation Bio, Inc. | 0.08% | $5.02M |
| 122 | Geron Corp. | 0.08% | $4.88M |
| 123 | Evotec SE | 0.08% | $4.73M |
| 124 | Tourmaline Bio, Inc. | 0.08% | $4.69M |
| 125 | UroGen Pharma Ltd. | 0.08% | $4.65M |
| 126 | Xencor, Inc. | 0.08% | $4.63M |
| 127 | AnaptysBio, Inc. | 0.08% | $4.62M |
| 128 | Enliven Therapeutics, Inc. | 0.08% | $4.60M |
| 129 | CorMedix, Inc. | 0.08% | $4.59M |
| 130 | Fortrea Holdings, Inc. | 0.08% | $4.49M |
| 131 | Kura Oncology, Inc. | 0.07% | $4.39M |
| 132 | Trevi Therapeutics, Inc. | 0.07% | $4.36M |
| 133 | Anavex Life Sciences Corp. | 0.07% | $4.36M |
| 134 | Taysha Gene Therapies, Inc. | 0.07% | $4.27M |
| 135 | CareDx, Inc. | 0.07% | $4.26M |
| 136 | Nurix Therapeutics, Inc. | 0.07% | $4.08M |
| 137 | Relay Therapeutics, Inc. | 0.07% | $4.01M |
| 138 | Theravance Biopharma, Inc. | 0.07% | $3.99M |
| 139 | Arbutus Biopharma Corp. | 0.07% | $3.98M |
| 140 | ORIC Pharmaceuticals, Inc. | 0.07% | $3.95M |
| 141 | Castle Biosciences, Inc. | 0.06% | $3.78M |
| 142 | Myriad Genetics, Inc. | 0.06% | $3.77M |
| 143 | Iovance Biotherapeutics, Inc. | 0.06% | $3.75M |
| 144 | Ginkgo Bioworks Holdings, Inc. | 0.06% | $3.48M |
| 145 | Oruka Therapeutics, Inc. | 0.06% | $3.48M |
| 146 | ARS Pharmaceuticals, Inc. | 0.06% | $3.41M |
| 147 | OPKO Health, Inc. | 0.06% | $3.27M |
| 148 | ArriVent Biopharma, Inc. | 0.05% | $3.24M |
| 149 | Tango Therapeutics, Inc. | 0.05% | $3.23M |
| 150 | Arvinas, Inc. | 0.05% | $3.23M |
Posiciones de ETF
SEC Form N-PORT data · Reported quarterly, filed with a lag · For reference only · Not investment advice